Company Filing History:
Years Active: 2022
Title: Karamjit Jandu: Innovator in Cardiovascular Treatments
Introduction
Karamjit Jandu is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cardiovascular diseases.
Latest Patents
Karamjit Jandu holds a patent for PCSK9 inhibitors and methods of use thereof. This invention relates to novel heteroaryl compounds of Formula (I) and pharmaceutical preparations thereof. The invention further encompasses methods of treating or preventing cardiovascular diseases, as well as methods for treating sepsis or septic shock, using the novel heterocyclic compounds disclosed in the patent. He has 1 patent to his name.
Career Highlights
Karamjit Jandu is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work focuses on innovative solutions that address critical health challenges.
Collaborations
Some of his notable coworkers include Michael H Serrano-Wu and Mark Chambers, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Karamjit Jandu's work in developing PCSK9 inhibitors showcases his commitment to advancing medical science and improving patient outcomes. His contributions are vital in the ongoing fight against cardiovascular diseases.